YM BioSciences Announces FDA Clearance for Phase II Nimotuzumab Trials into USA

News   Jan 27, 2010

 
YM BioSciences Announces FDA Clearance for Phase II Nimotuzumab Trials into USA
 
 
 

RELATED ARTICLES

Autism Risk Higher if Pregnant Mothers Have Infection Requiring Hospitalization

News

Studies have shown that mothers who experience an infection severe enough to require hospitalization during pregnancy are at higher risk of having a child with autism.

READ MORE

£2.2M Collaboration to Fuel Drug Developments for HIV

News

A collaboration between the University of Liverpool and the Johns Hopkins University School of Medicine (JHUSM) has been awarded a further £2.2M ($3M) to develop sophisticated new medicines for HIV.

READ MORE

Agilent Obtains U.S. FDA Approval for GenetiSure Dx Postnatal Assay

News

Agilent Technologies has obtained 510(k) clearance from the FDA for the GenetiSure Dx Postnatal Assay: its first comparative genomic hybridization (CGH) assay for diagnostic use.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE